GSK and Roche tell MPs that more clinical trial data should be publishedBMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f2639 (Published 24 April 2013) Cite this as: BMJ 2013;346:f2639
- Adrian O’Dowd
Two of the world’s largest drug companies have told MPs in parliament that they support a policy of publishing all clinical trial data.
A leading academic and clinician has, however, questioned their assertions and challenged them over how closely their promises would manifest into action.
MPs on the House of Commons Science and Technology Committee held an evidence session on 22 April for their inquiry into clinical trials. The inquiry is in the context of the European Commission’s proposal to revise the clinical trials directive that regulates trials in the United Kingdom and comes after concerns raised about transparency and disclosure of all trial data: drug companies are entitled to conduct numerous clinical trials on drugs but publish selectively.
MPs asked witnesses whether all clinical trials funded by …
Log in using your username and password
Log in through your institution
Sign up for a free trial